ArticleFrontiers in plant science2022
Genetic dissection of cassava brown streak disease in a genomic selection population.
Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Advances and prospects of genomic-assisted breeding in roots, tubers, and banana crops.Frontiers in plant science · 2026Review
- Genome-wide association study of cassava brown streak disease resistance in cassava germplasm conserved in South America.Scientific reports · 2024Article
- Genome-wide association study for yield and quality of granulated cassava processed product.The plant genome · 2024Article
- Identification of Genomic Regions for Traits Associated with Flowering in Cassava (Plants (Basel, Switzerland) · 2024Article
- Genetic complexity of cassava brown streak disease: insights from qPCR-based viral titer analysis and genome-wide association studies.Frontiers in plant science · 2024Article
- Genetic analysis of cassava brown streak disease root necrosis using image analysis and genome-wide association studies.Frontiers in plant science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cassava brown streak disease (CBSD) is a major threat to food security in East and central Africa. Breeding for resistance against CBSD is the most economical and sustainable way of addressing this challenge. Methods: This study seeks to assess the (1) performance of CBSD incidence and severity; (2) identify genomic regions associated with CBSD traits and (3) candidate genes in the regions of interest, in the Cycle 2 population of the National Crops Resources Research Institute. Results: A total of 302 diverse clones were screened, revealing that CBSD incidence across growing seasons was 44%. Severity scores for both foliar and root symptoms ranged from 1.28 to 1.99 and 1.75 to 2.28, respectively across seasons. Broad sense heritability ranged from low to high (0.15 - 0.96), while narrow sense heritability ranged from low to moderate (0.03 - 0.61). Five QTLs, explaining approximately 19% phenotypic variation were identified for CBSD severity at 3 months after planting on chromosomes 1, 13, and 18 in the univariate GWAS analysis. Multivariate GWAS analysis identified 17 QTLs that were consistent with the univariate analysis including additional QTLs on chromosome 6. Seventy-seven genes were identified in these regions with functions such as catalytic activity, ATP-dependent activity, binding, response to stimulus, translation regulator activity, transporter activity among others. Discussion: These results suggest variation in virulence in the C2 population, largely due to genetics and annotated genes in these QTLs regions may play critical roles in virus initiation and replication, thus increasing susceptibility to CBSD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.